ACAM Inhibitors
ACAM inhibitors belong to a class of chemical compounds that have garnered interest in the fields of molecular biology and pharmacology due to their ability to modulate specific cellular processes. ACAM, or Anterior Cingulate and Anterior Insula Mastermind, is a transcriptional coactivator that plays a crucial role in regulating gene expression. This coactivator is known for its involvement in the transcriptional control of genes associated with neural development, synaptic plasticity, and neuronal differentiation. ACAM inhibitors are designed to interact with the active site or binding domain of the ACAM protein, effectively inhibiting its coactivator function and affecting the expression of genes under its influence.
Structurally, ACAM inhibitors are tailored to selectively target the active site of ACAM, ensuring their specificity for this particular coactivator. By inhibiting ACAM, these compounds may disrupt the normal transcriptional regulation of genes associated with neural development and synaptic plasticity. The study of ACAM inhibitors is of significant interest to researchers as it provides insights into the regulatory mechanisms governing essential cellular functions in the nervous system. This knowledge contributes to our understanding of basic neurobiology and may have implications in various research areas, including neuroscience, neurodevelopmental disorders, and neural differentiation. However, further research is required to fully explore the extent of their applications and their impact on cellular physiology in the context of neural development and function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
As a PKC activator, it could influence various signaling pathways, potentially affecting CLMP expression. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
A specific PKC inhibitor, which might impact signaling pathways regulating CLMP expression. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor, could affect multiple signaling pathways, potentially influencing CLMP expression. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Calmodulin antagonist, could impact calcium signaling and indirectly influence CLMP expression. | ||||||
LY-333,531 Hydrochloride | 169939-93-9 | sc-364215 sc-364215A | 1 mg 5 mg | $94.00 $287.00 | 6 | |
A specific inhibitor of PKC beta, which could affect signaling pathways involved in CLMP expression. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
A classical PKC inhibitor, potentially influencing signaling pathways that regulate CLMP expression. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $92.00 $245.00 | 17 | |
A potent PKC inhibitor, might affect various cellular processes and CLMP expression. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
A Ca2+/calmodulin-dependent protein kinase II inhibitor, could influence signaling pathways affecting CLMP. | ||||||
PD 169316 | 152121-53-4 | sc-204168 sc-204168A sc-204168B sc-204168C | 1 mg 5 mg 10 mg 25 mg | $88.00 $156.00 $281.00 $461.00 | 3 | |
A p38 MAPK inhibitor, potentially impacting signaling pathways that regulate CLMP expression. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
Another p38 MAPK inhibitor, which could affect CLMP expression through cellular signaling pathways. | ||||||